Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
17 hedge funds and large institutions have $47.6M invested in Ocean Biomedical, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 37 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
56% less capital invested
Capital invested by funds: $108M → $47.6M (-$60.5M)
60% less funds holding
Funds holding: 43 → 17 (-26)
70% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$20.7M |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$14.8M |
| 3 |
CCFM
Cohen & Co Financial Management
New York
|
+$12.8M |
| 4 |
QL
Quarry LP
New York
|
+$1.94M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$530K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$8.29M |
| 2 |
SCM
Saba Capital Management
New York
|
-$7.63M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$6.25M |
| 4 |
ASM
ATW SPAC Management
New York
|
-$6.24M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$6.23M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EFI
51
EHP Funds Inc
Toronto,
Canada
| – | -$260K | -25,000 | Closed |
|
|
SOA
52
Sea Otter Advisors
Miami,
Florida
| – | -$260K | -25,000 | Closed |
|
53
Blackstone Inc
New York
| – | -$151K | -14,500 | Closed |
|
|
EC
54
Elequin Capital
New York
| – | -$2.69K | -259 | Closed |
|
OCEA Hedge Fund Activity: Q1 2023 in Review
17 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q1 2023, worth a combined $47.6M — down 56% from $108M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of OCEA and 11 opened new positions — a net loss of 26 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Polar Asset Management Partners, adding an estimated $20.7M. The largest seller was Shaolin Capital Management, exiting entirely with an estimated $8.29M sold.
- 17 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q1 2023, down from 43 in Q4 2022.
- Funds reported $47.6M of Ocean Biomedical, Inc. Common Stock stock for Q1 2023, down 56% quarter-over-quarter.
- 11 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q1 2023 and 37 closed out, a net change of -26 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q1 2023 was Polar Asset Management Partners, an estimated $20.7M added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q1 2023 was Shaolin Capital Management, an estimated $8.29M sold.
Based on aggregated 13F filings for Q1 2023.